Pregnancy-associated malaria (PAM) arises from sequestration of Plasmodium falciparum-
parasitized erythrocytes (PE) in the placenta, leading to chronic symptoms in the expectant …

The receptor-binding domain of Plasmodium vivax Duffy-binding protein, region II (PvRII), is
an attractive candidate for a vaccine against P. vivax malaria. Here, we have studied the …

VAR2CSA is the placental-malaria–specific member of the antigenically variant Plasmodium
falciparum erythrocyte membrane protein 1 (PfEMP1) family. It is expressed on the surface of …

The human malaria parasite, Plasmodium falciparum, is able to evade spleen-mediated
clearing from blood stream by sequestering in peripheral organs. This is due to the adhesive …

Malaria merozoites require the presence of specific surface receptors on the red blood cell
for invasion. Plasmodium vivax, requires the Duffy blood group antigen as an obligate …

Pregnancy‐associated malaria, a manifestation of severe malaria, is the cause of up to
200,000 infant deaths a year, through the effects of placental insufficiency leading to growth …

In Plasmodium falciparum–endemic areas, pregnancy-associated malaria (PAM) is an
important health problem. The condition is precipitated by accumulation of parasite-infected …

Background Malaria in pregnancy is a major cause of poor maternal and infant health, and
is associated with the sequestration of P. falciparum-infected erythrocytes (IE) in the …

Pregnancy-associated malaria is a major health problem, which mainly affects primigravidae
living in malaria endemic areas. The syndrome is precipitated by accumulation of infected …

Plasmodium falciparum placental parasites from Cameroon have been shown to express
surface variant var genes encoding Duffy binding–like (DBL)–γ domains that bind …